High-quality products
Reliable performance
In Vivo Pharmacodynamic Evaluation of B-luc MIA Paca-2 #4 Cells Induced Pancreatic Cancer Models (CAT#: STEM-AE-0656-LGZ)
Introduction
Cancer type: Pancreatic cancer
Cell line: B-luc MIA Paca-2 #4
Clone: Single clone
Inoculation: Orthotopic
Principle
By seeding tumor cells at organ-specific sites of the original tumor, in situ models simulate the initial lesion and establish better tumor, stroma, and immune component interactions than subcutaneous implants.
Applications
Pancreatic Cancer
Procedure
1. Disease model construction.
2. Mice dosing.
3. Efficacy monitoring.
4. Biochemical detection of tissue samples.
2. Mice dosing.
3. Efficacy monitoring.
4. Biochemical detection of tissue samples.
Materials
• Sample Type: liquid or powder
Other recommended products
-
In Vivo Pharmacodynamic Evaluation of Calu3 Cell Line Based Lung Cancer (CAT#: STEM-AE-0079-LGZ)
-
In Vivo Pharmacodynamic Evaluation of B-hCD3E/hCD20 Mice (Immune Checkpoint Humanized Mice) (CAT#: STEM-AE-0261-LGZ)
-
In Vivo Pharmacodynamic Evaluation of SNU-5 Cell Line Based Gastric Cancer (CAT#: STEM-AE-0053-LGZ)
-
In Vivo Pharmacodynamic Evaluation of B-hGAS6 Mice (Immune Checkpoint Humanized Mice) (CAT#: STEM-AE-0189-LGZ)
-
In Vivo Pharmacodynamic Evaluation of B-hTIGIT Mice© (Immune Checkpoint Humanized Mice) (CAT#: STEM-AE-0359-LGZ)
-
In Vivo Pharmacodynamic Evaluation of B-hHVEM MC38 Cells Induced Tumor Models (CAT#: STEM-AE-0173-LGZ)
-
In Vivo Pharmacodynamic Evaluation of Renca Cell Line Based Kidney Cancer (CAT#: STEM-AE-0059-LGZ)
-
In Vivo Pharmacodynamic Evaluation of B-hCTLA4/hTNFR2 Mice (Immune Checkpoint Humanized Mice) (CAT#: STEM-AE-0273-LGZ)
Wide range of applications
For various laboratory needs
Expert support
Professional service team
Fast delivery
Global shipping